Literature DB >> 35707153

Antibacterial Nanoassembled Calix[4]arene Exposing Choline Units Inhibits Biofilm and Motility of Gram Negative Bacteria.

Grazia Maria Letizia Consoli1, Giuseppe Granata1, Giovanna Ginestra2, Andreana Marino2, Giovanni Toscano2, Antonia Nostro2.   

Abstract

The high incidence of antibiotic resistance and biofilm-associated infections is still a major cause of morbidity and mortality and triggers the need for new antimicrobial drugs and strategies. Nanotechnology is an emerging approach in the search for novel antimicrobial agents. The aim of this study was to investigate the inherent antibacterial effects of a self-assembling amphiphilic choline-calix[4]arene derivative (Chol-Calix) against Gram negative bacteria. Chol-Calix showed activity against Escherichia coli and Pseudomonas aeruginosa, including antibiotic-resistant strains, and affected the bacterial biofilm and motility. The activity is likely related to the amphipathicity and cationic surface of Chol-Calix nanoassembly that can establish large contact interactions with the bacterial surface. Chol-Calix appears to be a promising candidate in the search for novel nanosized nonconventional antimicrobials.
© 2022 American Chemical Society.

Entities:  

Year:  2022        PMID: 35707153      PMCID: PMC9190052          DOI: 10.1021/acsmedchemlett.2c00015

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.632


  42 in total

Review 1.  Bio-Applications of Calix[n]arene Capped Silver Nanoparticles.

Authors:  Yannick Tauran; Beomjoon Kim; Anthony W Coleman
Journal:  J Nanosci Nanotechnol       Date:  2015-09

Review 2.  Functionalized calix[4]arenes as potential therapeutic agents.

Authors:  Muhammad Moazzam Naseer; Mukhtiar Ahmed; Shahid Hameed
Journal:  Chem Biol Drug Des       Date:  2017-02       Impact factor: 2.817

3.  Synthesis of a calix[4]arene derivative exposing multiple units of fucose and preliminary investigation as a potential broad-spectrum antibiofilm agent.

Authors:  Giuseppe Granata; Stefano Stracquadanio; Grazia Maria Letizia Consoli; Viviana Cafiso; Stefania Stefani; Corrada Geraci
Journal:  Carbohydr Res       Date:  2019-03-13       Impact factor: 2.104

4.  Quaternary Ammonium Salt-Based Cross-Linked Micelles to Combat Biofilm.

Authors:  Fangqin Liu; Dengfeng He; Yunlong Yu; Lei Cheng; Shiyong Zhang
Journal:  Bioconjug Chem       Date:  2019-02-12       Impact factor: 4.774

5.  PA-1, a novel synthesized pyrrolizidine alkaloid, inhibits the growth of Escherichia coli and Staphylococcus aureus by damaging the cell membrane.

Authors:  Na Li; Sheng-nan Tan; Jian Cui; Na Guo; Wei Wang; Yuan-gang Zu; Shuang Jin; Xian-xiu Xu; Qun Liu; Yu-jie Fu
Journal:  J Antibiot (Tokyo)       Date:  2014-06-04       Impact factor: 2.649

6.  Nanoscale analysis of the effects of antibiotics and CX1 on a Pseudomonas aeruginosa multidrug-resistant strain.

Authors:  C Formosa; M Grare; E Jauvert; A Coutable; J B Regnouf-de-Vains; M Mourer; R E Duval; E Dague
Journal:  Sci Rep       Date:  2012-08-14       Impact factor: 4.379

Review 7.  Antimicrobial applications of nanotechnology: methods and literature.

Authors:  Justin T Seil; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2012-06-06

Review 8.  Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action.

Authors:  Ranita Roy; Monalisa Tiwari; Gianfranco Donelli; Vishvanath Tiwari
Journal:  Virulence       Date:  2018-01-01       Impact factor: 5.882

9.  Adhesion and bactericidal properties of nanostructured surfaces dependent on bacterial motility.

Authors:  Keisuke Jindai; Kazuki Nakade; Kyosuke Masuda; Takashi Sagawa; Hiroaki Kojima; Tomohiro Shimizu; Shoso Shingubara; Takeshi Ito
Journal:  RSC Adv       Date:  2020-02-04       Impact factor: 4.036

10.  2-Heptylcyclopropane-1-Carboxylic Acid Disperses and Inhibits Bacterial Biofilms.

Authors:  Zoe L Harrison; Rukhsana Awais; Michael Harris; Babatunde Raji; Brian C Hoffman; Daniel L Baker; Jessica Amber Jennings
Journal:  Front Microbiol       Date:  2021-06-09       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.